Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
-
301
-
302
-
303
-
304
-
305
-
306
-
307
-
308
-
309
Rac1 activity decreases in the presence of DECMA-1 and E-cadherin:Fc in 3-D cell aggregates.
Published 2011“…Bar graphs show quantification of E-cadherin fluorescence intensity at cell-cell contacts for DECMA-1 Fab' fragments (D) or E-cadherin:Fc; error bars are SEM of 50 independent cell-cell contacts. Bars: 10 µm and 5 µm.…”
-
310
GluN2A(D731N) decreases channel open probability.
Published 2017“…(<b>D,E</b>) The channel open probability was evaluated by measuring the degree of MTSEA (200 μM) potentiation using TEVC recordings from <i>Xenopus</i> oocytes expressing the WT GluN2A (<i>left panel</i>) or the mutant GluN2A(D731N) (<i>right panel</i>) coexpressed with GluN1(A652C) at a holding potential of -40 mV in presence of EC<sub>50</sub> concentrations of glutamate with saturating concentration (100 μM) of glycine (open bar) and 0.2 mM MTSEA (closed bar). …”
-
311
-
312
-
313
-
314
-
315
-
316
-
317
Annual number of outpatient visits in recurrence and non-recurrence groups.
Published 2025“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
318
-
319
-
320
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022“…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”